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doi:10.1016/j.ejvs.2010.11.006Abstract Introduction: Cardiac arrhythmias are a major cause for morbidity and mortality in
patients undergoing non-cardiac vascular surgery.
Report: An implantable loop recorder (Reveal XT) was used for continuous heart rhythmmoni-
toring to detect perioperative arrhythmias in a 69-year-old man undergoing major vascular
surgery for an infected aortobifemoral prosthesis. The Reveal detected several episodes of
asymptomatic new-onset atrial fibrillation postoperatively, associated with elevated serum
levels of troponin-T and N-terminal pro-B-type natriuretic peptide NT-proBNP).
Discussion: Continuous heart rhythm monitoring with assessment of serum cardiac biomarkers
may allow early identification and treatment of patients at high risk of perioperative cardiovas-
cular complications, in particular, cardiac arrhythmias.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Cardiovascular complications are a major cause for
morbidity and mortality in vascular surgery patients.1 Inans, Department of Vascular
Gravendijkwal 230, 3015 CE
el.: þ31107034613; fax:
smusmc.nl (D. Poldermans).
ty for Vascular Surgery. Publisheaddition to ischaemic complications, up to 20% of patients
develop cardiac arrhythmias postoperatively, of which atrial
fibrillation (AF) is the most common form. Consequences of
cardiac arrhythmias include sudden cardiac death, conges-
tive heart failure (CHF) and stroke.2 Due to their asymp-
tomatic and atypical character, the majority of these
perioperative arrhythmias are missed, and, hence, under-
treated.2 We hypothesise that continuous heart rhythm
monitoring could identify patients with cardiac arrhythmias,
and present their relation with cardiac serum biomarkers.d by Elsevier Ltd. All rights reserved.
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A 69-year-old man presented with an infected prosthetic
aortobifemoral graft. His medical history was positive for
cardiovascular risk factors,3 including diabetes, hyperten-
sion, coronary artery reconstruction, and an aortic bifur-
cation graft for stenotic aortoiliac disease. Preoperative
test showed normal renal function.4 He was admitted with
fever and blood cultures positive for Streptococcus angi-
nosus. Computed tomography (CT) angiography revealed an
intimate connection between the aortic graft and the
duodenum accompanied by fluid collections, consistent
with prosthesis infection. The decision was made to remove
the infected graft. The patient had no history of arrhyth-
mias, and at preoperative work-up, his electrocardiograph
(ECG) showed normal sinus rhythm (SR). Dobutamine
echocardiography demonstrated a reduced left ventricular
ejection fraction (LVEF 30e40%), septal hypokinesia, but no
stress-inducible ischaemia. Preoperative serum cardiac
troponin-T (cTnT) was within normal limits, whereas
N-terminal pro-b-type natriuretic peptide (NT-proBNP) was
elevated (1191 pg ml1).
Two days prior to surgery, an implantable loop recorder
(ILR; Reveal XT, Medtronic Inc., Minneapolis, MN, USA) was
implanted subcutaneously for continuous heart rhythm
monitoring. To detect myocardial ischaemia, continuous
12-lead ECG monitoring (Holter) was performed. Prior to
surgery, the Reveal device was read, showing no
arrhythmias. The infected aortic prosthesis was removed
with venous patch angioplasty of the common femoral
arteries3. As there were no signs of acute limb ischaemia, in
the presence of partially patent iliac arteries, no central
reconstruction was performed during the index procedure.
The day after surgery, the patient developed new-onset
paroxysmal AF, not responding to chemical cardioversion
with amiodarone. He was converted electrically, after
removal of the Holter monitor, at days 1 and 3 after surgery.
At the end of day 3, the patient developed peritonitis
requiring a relaparotomy with partial duodenectomy and
duodenojejunostomy. After a prolonged septic period and
intensive care unit (ICU) stay, the patient eventually recov-
ered and was discharged with anticoagulation, beta blocker
and statin therapy. A below-the-knee amputation was per-
formed 4 months after the index procedure for irreversible
ischaemia of the right forefoot.0 10 20 30
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Figure 1 Perioperative biomarker measurement and detec-
tion of AF.Although postoperative Holter and standard 12-lead ECG
recording showed no signs of myocardial ischaemia, serum
levels of cTnT peaked at days 3, 8, 13 and 18 post-
operatively to a maximum of 0.62 mg l1 in the absence of
chest pain (Fig. 1). Postoperative levels of NT-proBNP
showed a similar pattern. Interestingly, Reveal showed
that episodes of AF were paralleled by peaks in serum cTnT
and NT-proBNP levels. The last episode of paroxysmal AF
was detected 19 days after the index surgery, and the
patient returned to SR afterwards. Despite electrical
cardioversion, the Reveal recordings remained of good
quality.
Discussion
This case shows that continuous heart rhythm monitoring
has excellent recording quality and could improve the
detection of perioperative arrhythmias.
The incidence of arrhythmias depends on the type of
cardiac monitoring, with better estimates being obtained
using continuous monitoring. In a study by Mathew et al., it
was noted that continuous ECG monitoring diagnoses 76.8%
of perioperative arrhythmias, whereas intermittent 12-lead
ECG or physical examination detect only 17.5% and 12.8%,
respectively.5 In our case, continuous monitoring was per-
formed with an ILR. The Reveal device is easily implanted
in a subcutaneous pocket in a left parasternal position at
the level of the 4th or the 5th intercostal space, in less than
30 min. The device can be left in situ up to 3 years after
implantation and sustains electrocardioversion.
Strikingly, the episodes of AF were paralleled with
increased levels of cTnT and NT-proBNP. With respect to
the underlying pathophysiological mechanism, we suggest
that subclinical myocardial ischaemia, as revealed by
increased serum cTnT, induces cardiomyocyte contractile
dysfunction, resulting in cardiomyocyte stretch and release
of NT-proBNP. Furthermore, cardiomyocyte stretch is
associated with myocyte depolarisation during diastole,
changing the action potential and causing abnormal
impulses by stretch-activated channel currents, which may
trigger arrhythmias.5 Transient and asymptomatic new-
onset AF during vascular surgery has been shown to be
associated with a fivefold increased risk for perioperative
and long-term cardiovascular events.1
In conclusion, continuous heart rhythm monitoring with
assessment of cardiac biomarkers may allow early identifi-
cation and treatment of patients at high risk of perioperative
cardiovascular complications, in particular, cardiac
arrhythmias.
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